WHO ICTRP trial

Improving opportunities for engagement for hospital inpatients with Huntington's…

ACTRN12610000994088 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting

Key facts

Trial ID ACTRN12610000994088
Public title Improving opportunities for engagement for hospital inpatients with Huntington's Disease
Scientific title Do Huntington's Disease inpatients in a subacute neurological ward who receive Diversional Therapy, compared to those you receive normal ward care, have an enhanced experience during their hospital admission?
Primary sponsor Calvary Health Care Bethlehem
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions Huntington's Disease; Huntington's Disease;Neurological - Neurodegenerative diseases;Human Genetics and Inherited Disorders - Other human genetics and inherited disorders
Interventions Ward-based Diversional Therapy program. A Diversional Therapist will be employed 6 hours/day for 4 days/week to provide individual and group Diversional Therapy sessions, for a period of 6 months.
Registration date Nov 16, 2010
Target size 20
Secondary IDs Nil
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations